Investments
13Portfolio Exits
3About Kuwait National Technology Enterprises Corporation
NTEC was created to play a role in servicing major stakeholders in Kuwait with their technology needs. NTEC's model is to provide solutions by accessing a specialized layer of technology that is based on Intellectual Property and is at the pre-commercialization stage. NTEC can help address Kuwait's needs for these technologies.
Latest Kuwait National Technology Enterprises Corporation News
Jun 3, 2012
KUWAIT CITY, June 2, (KUNA): Kuwait National Technology Enterprises Company NTEC inked Saturday a deal with Helio-centris Energy Solutions AG, a leading specialist in environmentally friendly energy storage solutions based in Berlin, to establish Hel...
Kuwait National Technology Enterprises Corporation Investments
13 Investments
Kuwait National Technology Enterprises Corporation has made 13 investments. Their latest investment was in CardioMems as part of their Series G on May 5, 2010.

Kuwait National Technology Enterprises Corporation Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/19/2010 | Series G | CardioMems | $37.9M | No | Aperture Venture Partners, Arboretum Ventures, Arcapita, Boston Millennia Partners, Deerfield Management, Easton Capital, Flare Capital Partners, Guidant Compass Group, Johnson & Johnson Innovation, Medtronic, Rockport Venture Partners, St. Jude Medical, Vision Capital Advisors, and Vision Opportunity Capital Management | |
4/13/2010 | Series D | Oxford Immunotec | $26M | Yes | 1 | |
8/24/2009 | Series F | CardioMems | $22.1M | Yes | Aperture Venture Partners, Arboretum Ventures, Arcapita, Boston Millennia Partners, Deerfield Management, Easton Capital, Flare Capital Partners, Guidant Compass Group, Johnson & Johnson Innovation, Medtronic, Rockport Venture Partners, St. Jude Medical, Vision Capital Advisors, and Vision Opportunity Capital Management | |
8/6/2009 | Series G | |||||
5/16/2009 | Series D |
Date | 5/19/2010 | 4/13/2010 | 8/24/2009 | 8/6/2009 | 5/16/2009 |
---|---|---|---|---|---|
Round | Series G | Series D | Series F | Series G | Series D |
Company | CardioMems | Oxford Immunotec | CardioMems | ||
Amount | $37.9M | $26M | $22.1M | ||
New? | No | Yes | Yes | ||
Co-Investors | Aperture Venture Partners, Arboretum Ventures, Arcapita, Boston Millennia Partners, Deerfield Management, Easton Capital, Flare Capital Partners, Guidant Compass Group, Johnson & Johnson Innovation, Medtronic, Rockport Venture Partners, St. Jude Medical, Vision Capital Advisors, and Vision Opportunity Capital Management | Aperture Venture Partners, Arboretum Ventures, Arcapita, Boston Millennia Partners, Deerfield Management, Easton Capital, Flare Capital Partners, Guidant Compass Group, Johnson & Johnson Innovation, Medtronic, Rockport Venture Partners, St. Jude Medical, Vision Capital Advisors, and Vision Opportunity Capital Management | |||
Sources | 1 |
Kuwait National Technology Enterprises Corporation Portfolio Exits
3 Portfolio Exits
Kuwait National Technology Enterprises Corporation has 3 portfolio exits. Their latest portfolio exit was CardioMems on June 02, 2014.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/2/2014 | Acquired | 1 | |||
Date | 6/2/2014 | ||
---|---|---|---|
Exit | Acquired | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 1 |
Loading...